ERNESTPHARMACEUTICAL Products
Nagpur +919405476170 ernestpharmanagpur@gmail.com
919405476170
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

ERNESTPHARMACEUTICAL 6a6b18daf529a9b4cb9c881c Products https://www.ernestimpex.in
Home Products Cresp Darbepoetin Alfa Injection
Cresp Injection is a
Cresp Injection is a
COD not available
Nephrology Medicine by Cresp

Cresp Darbepoetin Alfa Injection - Darbepoetin Alfa Composition

Share with
Share this on :

Description

Product details

Cresp Injection is an erythropoiesis-stimulating medicine containing Darbepoetin Alfa. It is used for the management of certain types of anaemia, particularly anaemia associated with chronic kidney disease (CKD) and chemotherapy-related anaemia in suitable patients. Darbepoetin Alfa stimulates the bone marrow to increase red blood cell production, helping healthcare professionals manage reduced haemoglobin levels. Available Cresp Variants Product Variant Strength Presentation Cresp 25 mcg 25 mcg Pre-Filled Syringe (PFS) Cresp 40 mcg 40 mcg Pre-Filled Syringe (PFS) Cresp 40 mcg 40 mcg Vial Cresp 60 mcg 60 mcg Pre-Filled Syringe (PFS) Uses & Benefits Anaemia Associated with Chronic Kidney Disease Reduced kidney function can affect the body's ability to maintain adequate red blood cell production. Cresp may be prescribed to stimulate red blood cell formation and support haemoglobin management in patients with CKD-related anaemia. Chemotherapy-Related Anaemia Certain chemotherapy treatments can reduce red blood cell and haemoglobin levels. Cresp may be prescribed for appropriate cancer patients to support red blood cell production during chemotherapy. How to Use Cresp Injection should be used only under the supervision of a qualified healthcare professional. The appropriate strength, dose and treatment frequency are determined according to haemoglobin levels, medical condition and individual response to treatment. Do not select a strength or change the dose without medical advice. Possible Side Effects Reported side effects may include: High blood pressure Rash Injection-site discomfort Shortness of breath Cough Peripheral oedema Low blood pressure Convulsions Thromboembolic events Contact your healthcare professional if symptoms are severe, persistent or concerning. Product Specifications Composition: Darbepoetin Alfa Available Strengths: 25 mcg, 40 mcg and 60 mcg Dosage Form: Injection Presentations: Pre-Filled Syringe (PFS) and Vial Therapeutic Category: Anaemia Management / Erythropoiesis-Stimulating Agent Administration: As directed by a qualified healthcare professional

Other Specifications

Presentation :PFS & Vial
Available Strengths :25 mcg, 40 mcg, 60 mcg
  • Filter tags

Other Products

Related Products

MACQUIN Advanced Skin Soap is a skin cleansing bar with Kojic Acid, Niacinamide and Tea Tree Oil. It helps cleanse daily impurities and leaves skin feeling clean and refreshed. Formulated for brighter, healthier-looking skin, it complements your regular skincare routine.
View Details
MACQUIN Advanced Skin Soap
Azilsartan Medoxomil 40mg & 80mg Tablet Azilsmart contains Azilsartan Medoxomil, an angiotensin II receptor blocker (ARB) used for the management of hypertension. Azilsartan Medoxomil is a prodrug that is converted in the body to its active form, azilsartan. The active drug selectively blocks angiotensin II AT1 receptors, reducing the vasoconstrictive and aldosterone-related effects of angiotensin II. This helps blood vessels relax, decreases peripheral vascular resistance and supports effective control of elevated blood pressure. Azilsmart 40 mg and Azilsmart 80 mg provide different strength options for individualized antihypertensive therapy. Treatment should be prescribed according to the patient's blood-pressure response and overall clinical condition. Blood pressure, renal function and serum potassium may require monitoring during therapy. Product Variants: Product Active Ingredient Strength Azilsmart 40 mg Azilsartan Medoxomil 40 mg Azilsmart 80 mg Azilsartan Medoxomil 80 mg Uses of Azilsmart: Azilsartan Medoxomil is primarily used for: Management of hypertension (high blood pressure) Long-term blood-pressure control in appropriate patients Use alone or with other antihypertensive medicines when clinically indicated Mechanism of Action: Azilsartan Medoxomil is converted to active azilsartan, which selectively blocks angiotensin II from binding to AT1 receptors. This reduces vasoconstriction and aldosterone-mediated effects, resulting in reduced vascular resistance and lower blood pressure. Possible Side Effects: Potential adverse effects may include: Dizziness Low blood pressure Fatigue Increased serum potassium Changes in kidney function Patients with renal impairment, volume depletion or those using other medicines that affect the renin-angiotensin system may require additional monitoring.
View Details
Azilsartan Medoxomil 40mg & 80mg Tablet
Rosuvastatin Calcium & Fenofibrate F10 & F20 Tablet Rosufree-F is a combination lipid-lowering medicine containing Rosuvastatin Calcium and Fenofibrate. The formulation combines two medicines with complementary mechanisms and may be prescribed for selected patients with mixed dyslipidemia, particularly when both elevated cholesterol and triglyceride levels require management. Rosuvastatin belongs to the statin class and inhibits HMG-CoA reductase, an enzyme involved in hepatic cholesterol synthesis. This action primarily helps reduce LDL cholesterol. Fenofibrate is a fibrate that activates PPAR-alpha (peroxisome proliferator-activated receptor alpha) and primarily helps reduce elevated triglyceride levels while influencing other lipid parameters. Rosufree-F should be used under medical supervision along with appropriate dietary and lifestyle measures. Because statin-fibrate combination therapy can increase the risk of muscle-related adverse effects, patients should report unexplained muscle pain, tenderness or weakness. Lipid profile, liver function and renal function may require assessment depending on the patient's clinical condition. Uses of Rosufree-F: Rosuvastatin and Fenofibrate combination therapy may be used for: Management of mixed dyslipidemia Reduction of elevated LDL cholesterol Management of elevated triglyceride levels Improvement of lipid parameters when combination therapy is clinically appropriate How Rosufree-F Works: Component Main Action Rosuvastatin Calcium Inhibits HMG-CoA reductase and reduces hepatic cholesterol synthesis Fenofibrate Activates PPAR-alpha and enhances triglyceride-rich lipoprotein metabolism Combined Effect Targets both cholesterol and triglyceride abnormalities Possible Side Effects: Potential adverse effects can include: Headache Nausea or digestive discomfort Muscle pain or weakness Increased liver enzymes Changes in renal function in susceptible patients Severe or persistent muscle symptoms require medical evaluation because statin-fibrate combinations can rarely be associated with serious muscle injury.
View Details
Rosuvastatin Calcium & Fenofibrate F10 & F20 Tablet

Have any question or need any business consultation?

Contact Us

Have any question or need any business consultation?

Contact Us
Chat with us